OCT Clinical Trials Successfully Recruits 700 Patients for Phase III...

OCT, Eastern Europe’s leading CRO, partners with UK-based Futura Medical; completes clinical trial enrollment for MED2002, a topical gel developed to treat erectile dysfunction.(PRWeb August 16, 2019)Read the full story at https://www.prweb.com/releases/oct_clinical_trials_successfully_recruits_700_patients_for_phase_iii_erectile_dysfunction_study/prweb16505766.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news